NAUT
Nautilus Biotechnology (NAUT)
$85
About Nautilus Biotechnology (NAUT)
Nautilus Biotechnology, Inc. is a development stage life sciences company, which creates platform technology for quantifying and unlocking the complexity of the proteome. Its products include Proteome Analysis System, Reagent Kits, and Software and Analysis. The company was founded by Sujal M. Patel and Parag Mallick in 2016 and is headquartered in Seattle, WA.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$2.54
52 Week Low
$0.62
Market cap
240.0M
Dividend yield
0.00%
Volume
--
Avg. volume
352,811
P/E ratio
-3.81
Nautilus Biotechnology News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$2.54
52 Week Low
$0.62
Market cap
240.0M
Dividend yield
0.00%
Volume
--
Avg. volume
352,811
P/E ratio
-3.81